Document is current

Article History

Received: 3 July 2022

Accepted: 11 September 2022

First Online: 13 October 2022

Declarations

:

: The NESMOS Department has received research funds from Motiva, Establishment Labs in 2017, and from GC Aesthetics in 2018 and 2020. The Department also received miniature breast implants from Establishment Labs, GC Aesthetics and Sebbin for research purposes in 2017. The Senior author would like to disclose that they serve as a paid consultant for BellaSeno GmbH, and for Notified Body 0373 carrying out CE Mark certification activities for the Italian Ministry of Health for the year 2021 and 2022, and that they received reimbursements from ICEAG in 2015 and SCHEER-WG in 2019, 2020 and 2021. They have no ownership or investment to disclose. Neither the corresponding author nor any of the coauthors have received any type of funding or other support from a sponsor/commercial entity/third party. All other authors hereby certify that, to the best of their knowledge, no financial support or benefit has been received, neither by themselves directly, nor by any member of their immediate family or any individual or entity with whom or with which they may have a significant relationship from any commercial source which is related directly or indirectly to the scientific work which is reported on in the article.

: The datasets obtained from the questionnaire used in this study did not contain personal, identifiable data, thus ethical committee approval and is not required for this type of study, but informed consent was administered to all patients.

: This retrospective observational study was conducted in accordance with the World Medical Association’s Declaration of Helsinki for ethical principles in medical research involving human subjects.